115 related articles for article (PubMed ID: 31144750)
1. Angiogenesis in bladder tissues is strongly correlated with urinary frequency and bladder pain in patients with interstitial cystitis/bladder pain syndrome.
Furuta A; Suzuki Y; Igarashi T; Koike Y; Kimura T; Egawa S; Yoshimura N
Int J Urol; 2019 Jun; 26 Suppl 1():35-40. PubMed ID: 31144750
[TBL] [Abstract][Full Text] [Related]
2. [EARLY EXPERIENCE OF INTRAVESICAL INSTILLATION OF DIMETHYL SULFOXIDE 50% SOLUTION FOR HUNNER TYPE INTERSTITIAL CYSTITIS IN A CLINIC].
Nanri M; Matsuo M
Nihon Hinyokika Gakkai Zasshi; 2022; 113(4):122-127. PubMed ID: 37866931
[TBL] [Abstract][Full Text] [Related]
3. The potential mechanism of treating IC/BPS with hyperbaric oxygen by reducing vascular endothelial growth inhibitor and hypoxia-inducible factor-1α.
Zhang J; Kang J; Wu L
Turk J Med Sci; 2024; 54(1):26-32. PubMed ID: 38812622
[TBL] [Abstract][Full Text] [Related]
4. Possible role of intravenous administration of mesenchymal stem cells to alleviate interstitial cystitis/bladder pain syndrome in a Toll-like receptor-7 agonist-induced experimental animal model in rat.
Tabata H; Sasaki M; Kataoka-Sasaki Y; Shinkai N; Ichihara K; Masumori N; Kocsis JD; Honmou O
BMC Urol; 2021 Nov; 21(1):156. PubMed ID: 34774029
[TBL] [Abstract][Full Text] [Related]
5. Validation study of new clinical scoring - "Apollo Clinical Scoring system" for bladder pain syndrome/interstitial cystitis and comparison of outcome with standard "O'Leary-Sant score".
Taneja R; Singh AK; Sharma A; Taneja N; Raheja A
Int Urogynecol J; 2023 Aug; ():. PubMed ID: 37642668
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic effect of modulating the NLRP3-regulated transforming growth factor-β signaling pathway on interstitial cystitis/bladder pain syndrome.
Shih HJ; Chang CY; Lai CH; Huang CJ
Biomed Pharmacother; 2021 Jun; 138():111522. PubMed ID: 34311526
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and Safety of Low-dose Oral Prednisolone for Patients with Refractory Hunner-type Interstitial Cystitis.
Akiyama Y; Niimi A; Nomiya A; Taguchi S; Yamada Y; Sato Y; Yamada D; Maeda D; Ushiku T; Kume H; Homma Y
Eur Urol Open Sci; 2023 Oct; 56():1-8. PubMed ID: 37822513
[TBL] [Abstract][Full Text] [Related]
8. Randomized multicenter clinical trial of myofascial physical therapy in women with interstitial cystitis/painful bladder syndrome and pelvic floor tenderness.
FitzGerald MP; Payne CK; Lukacz ES; Yang CC; Peters KM; Chai TC; Nickel JC; Hanno PM; Kreder KJ; Burks DA; Mayer R; Kotarinos R; Fortman C; Allen TM; Fraser L; Mason-Cover M; Furey C; Odabachian L; Sanfield A; Chu J; Huestis K; Tata GE; Dugan N; Sheth H; Bewyer K; Anaeme A; Newton K; Featherstone W; Halle-Podell R; Cen L; Landis JR; Propert KJ; Foster HE; Kusek JW; Nyberg LM;
J Urol; 2012 Jun; 187(6):2113-8. PubMed ID: 22503015
[TBL] [Abstract][Full Text] [Related]
9. Effects of electroacupuncture on refractory interstitial cystitis/bladder pain syndrome: A one-year follow-up case report.
Gao N; Zeng X; Wu L; Lin Z; Wang X; Wang W
Explore (NY); 2024; 20(4):602-605. PubMed ID: 38072764
[TBL] [Abstract][Full Text] [Related]
10. Urinary ATP may be a biomarker of interstitial cystitis/bladder pain syndrome and its severity.
Wu Y; He Y; Qi J; Wang S; Wang Z
Biomol Biomed; 2024 Jan; 24(1):170-175. PubMed ID: 37819233
[TBL] [Abstract][Full Text] [Related]
11. Serum anandamide and lipids associated with linoleic acid can distinguish interstitial cystitis/bladder pain syndrome from overactive bladder: An exploratory study.
Torimoto K; Ueda T; Gotoh D; Kano K; Miyake M; Nakai Y; Hori S; Morizawa Y; Onishi K; Shimizu T; Tomizawa M; Aoki J; Fujimoto K
Low Urin Tract Symptoms; 2023 Nov; 15(6):238-246. PubMed ID: 37688290
[TBL] [Abstract][Full Text] [Related]
12. Bladder instillations versus onabotulinumtoxinA injection for interstitial cystitis/bladder pain syndrome: A randomized clinical trial.
Welch EK; Dengler KL; Dicarlo-Meacham AM; Wheat JE; Pekny CJ; Aden JK; Vaccaro CM
Am J Obstet Gynecol; 2024 May; ():. PubMed ID: 38768800
[TBL] [Abstract][Full Text] [Related]
13. UPK3A
Peng L; Chen JW; Chen YZ; Zhang C; Shen SH; Liu MZ; Fan Y; Yang SQ; Zhang XZ; Wang W; Gao XS; Di XP; Ma YC; Zeng X; Shen H; Jin X; Luo DY
J Pathol; 2024 Jun; 263(2):203-216. PubMed ID: 38551071
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of intravesical dimethyl sulfoxide treatment for patients with refractory Hunner-type interstitial cystitis: Real-world data postofficial approval in Japan.
Akiyama Y; Niimi A; Nomiya A; Taguchi S; Yamada Y; Sato Y; Kawai T; Yamada D; Kume H; Homma Y
Int J Urol; 2024 Feb; 31(2):111-118. PubMed ID: 37817647
[TBL] [Abstract][Full Text] [Related]
15. Effects of onabotulinum toxin-A injection on sexual function in women with refractory interstitial cystitis/bladder pain syndrome: A prospective study.
Karaburun MC; Kubilay E; Öztuna D; Gökçe Mİ; Süer E; Gülpınar Ö
Low Urin Tract Symptoms; 2024 Mar; 16(2):e12511. PubMed ID: 38527461
[TBL] [Abstract][Full Text] [Related]
16. Optimal endoscopic treatment and partial cystectomy with or without bladder augmentation for Hunner-type interstitial cystitis.
Yu J; Lee CU; Lee KS; Ko KJ
Low Urin Tract Symptoms; 2023 Nov; 15(6):216-224. PubMed ID: 37750459
[TBL] [Abstract][Full Text] [Related]
17. Potential Role of Macrophage Polarization in the Progression of Hunner-Type Interstitial Cystitis.
Ko KJ; Kim G; Sung HH; Park WY; Lee KS
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255860
[TBL] [Abstract][Full Text] [Related]
18. Current Understanding and Future Perspectives of Interstitial Cystitis/Bladder Pain Syndrome.
Ueda T; Hanno PM; Saito R; Meijlink JM; Yoshimura N
Int Neurourol J; 2021 Jun; 25(2):99-110. PubMed ID: 34218637
[TBL] [Abstract][Full Text] [Related]
19. A Feasibility Study to Determine Whether Clinical Contrast Enhanced Magnetic Resonance Imaging can Detect Increased Bladder Permeability in Patients with Interstitial Cystitis.
Towner RA; Wisniewski AB; Wu DH; Van Gordon SB; Smith N; North JC; McElhaney R; Aston CE; Shobeiri SA; Kropp BP; Greenwood-Van Meerveld B; Hurst RE
J Urol; 2016 Mar; 195(3):631-8. PubMed ID: 26307161
[TBL] [Abstract][Full Text] [Related]
20. Validation of Distinct Bladder Pain Phenotypes Utilizing the MAPP Research Network Cohort.
Nettey OS; Gu C; Jackson NJ; Ackerman AL
Int Urogynecol J; 2024 Mar; 35(3):637-648. PubMed ID: 38300276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
